Kojin Therapeutics
United StatesEntry
2021
Hold
4yr
Exit
2025
Who owns Kojin Therapeutics?
Kojin Therapeutics is an American Biotech company, formerly owned by Leaps by Bayer and Cathay Capital, exited in 2025. No current private equity owner is on file.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Cathay CapitalCathay Health · 2021 · Growth
2 ownership periods · full history below
Key facts
HQUnited States
SectorBiotech
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2025.
Co-invest · 2 holders · 2021 · 2025
Leaps by BayerExited 2025
2021 · 2025(4yr) · Leaps by Bayer · 2015 · Evergreen
Leaps by Bayer exited Kojin Therapeutics in 2025 after 4 years.
Cathay CapitalExited 2025
2021 · 2025(4yr) · Cathay Health · 2021 · Growth
Cathay Capital exited Kojin Therapeutics in 2025 after 4 years.
More from Cathay Health
Other portfolio companies in the same fund.
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Kojin Therapeutics?
Kojin Therapeutics was formerly owned by Leaps by Bayer and Cathay Capital, exited in 2025. No current private equity owner is on file.
Who has owned Kojin Therapeutics over time?
Kojin Therapeutics has been through 2 private-equity ownership periods: Leaps by Bayer · via Leaps by Bayer · 2021–2025; Cathay Capital · via Cathay Health · 2021–2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue